Observational research has shown that the physical activity levels of survivors of hematological cancer are low, with deleterious health consequences. This review summarizes the research on exercise interventions in adult and pediatric hematological cancer survivors. We searched MEDLINE, SPORTDiscus, CINAHL, Embase, Cochrane and PEDro through September 2009 for exercise intervention studies in children and adults with any type of hematological cancer. In the 24 adult intervention studies reviewed, we found strong evidence (that is, X3 high-quality studies and X75% reporting a significant benefit) for a benefit on body composition. Weak, but promising, evidence (X3 high-quality studies, but o75% reporting a significant benefit) was found for cardiorespiratory fitness, fatigue, muscle strength, physical functioning and quality of life. In pediatric interventions (13 studies), we found strong evidence for a benefit on muscle strength and cardiorespiratory fitness, particularly, if training was conducted in the hospital setting. Evidence is weak for ankle dorsiflexion, physical functioning and body composition. No exerciserelated risks were identified in adults or children studies. Though more randomized controlled trials are needed, a growing body of literature supports the notion that regular physical activity is safe and has potential benefits for both adult and pediatric hematological cancer survivors.
Introduction
Interest in physical activity in hematological cancer survivors has largely focused on its potential to ameliorate the side effects of treatment. 1 Regular physical activity (for example, brisk walking for 30 or more minutes on most days of the week) has a beneficial effect on the chain of interactive events between the central nervous system and the contraction of the skeletal muscle that are involved in most types of activities. These events include blood oxygenation (which depends on pulmonary function), blood oxygen carrying capacity supply of oxygenated blood to the working muscles (which depends on cardiac output) and muscles ability to consume oxygen and to produce force while contracting. As a result, regular physical activity increases the ability to cope with activities of daily living, as well as the peak cardiorespiratory capacity (commonly expressed as peak oxygen uptake, VO 2peak ), of virtually all population groups. 2 Anticancer treatment has, however, the opposite effect. Radiation therapy often results in lung fibrosis, which decreases lung capacity and function. 3 Chemotherapy causes anemia, decreasing blood oxygen transport; it can also affect cardiac function, which reduces cardiac output, and skeletal muscle mass, leading to muscle atrophy. 4 Chemotherapy also induces gastrointestinal toxicities that can interfere with nutrition. 5, 6 Thus, in addition to having low levels of cardiorespiratory fitness and muscle strength, 7 individuals under cancer treatment can experience fatigue even during normal activities of daily living. 4 Pediatric cancer survivors are exposed to particularly adverse consequences of treatment, including diminished neurological function, impaired cardiac function, growth problems, altered endocrine function, osteoporosis and obesity. 8 Especially harmful is cranial radiotherapy. This therapy, which was used in the last two decades for high-risk acute lymphoblastic leukemia (ALL) (typically at 18 Gy dose), is strongly associated with physical inactivity during adulthood. 9 Boys and girls (7-19 years) who are long-term ALL survivors (41.5 years posttreatment) have significantly reduced cardiorespiratory fitness, and this reduction is correlated with cumulative chemotherapy dose. 7 Likewise, higher chemotherapy dose is associated with lower cardiac function. 3 Long-term survivors of ALL are more likely to be obese than the general population, which is itself a risk factor for adverse outcomes after disease. 9 Finally, longterm ALL survivors are at increased risk of having several physical inactivity-related diseases, such as cardiovascular disease, and osteoporosis. [10] [11] [12] Hematopoietic stem cell transplantation (HSCT), which includes both bone marrow and peripheral blood stem cell transplantation, typically occurs after radiation or chemotherapy in the more severe hematological malignancies, but is also used in the treatment of refractory solid tumors. The treatment process results in a decline in physical functioning owing to a loss of muscle mass/strength. 4 Muscle atrophy is associated with several transplant-related problems, including immunosuppressive therapy, bed rest and drug toxicities, for example, oral intestinal mucositis and diarrhea. 5, 6 Survivors also report fatigue, anxiety, depression and fear during and after treatment. 4 The risk of infection for HSCT patients is high, which can limit their options for physical activity during and after treatment.
The harmful effects of treatment are further aggravated by the typically low physical activity levels of survivors of hematological cancer, as shown by extensive observational research both in adults and children (see also, Supplementary Table 1) . The physical activity levels of adult hematological cancer survivors are indeed rather low and usually below the recommended levels. [13] [14] [15] [16] [17] [18] [19] Low physical activity levels impact a diverse set of outcomes, including fatigue 17 (though some controversy exists 20, 21 ), sleep, 20 quality of life (QOL) 16, 22 and risk of cardiovascular disease and hypothyroidism. 17 In ALL survivors, low physical activity levels begin during the first two decades of life. Child survivors of ALL have lower levels of physical activity than their healthy referents, 8, [23] [24] [25] leading to worse cardiorespiratory fitness, 7, [26] [27] [28] [29] [30] [31] physical function, 30 balance and coordination. 32 Identifying the effects of regular physical activity in adult and pediatric survivors of hematological cancer is thus of medical interest. Liu et al. 33 recently performed a systematic review on exercise interventions conducted in hematological cancer patients, including studies published up to September 2007. This area of research is growing considerably and several intervention studies in adult/children survivors of hematological cancer have been recently published in adults [34] [35] [36] [37] [38] [39] [40] and in children 28, [41] [42] [43] [44] [45] [46] [47] that were not included in the review by Liu et al. 33 Here, we summarize the intervention data related to all the possible effects of physical activity on adult and pediatric hematological cancer survivors. The information is also detailed extensively in Supplementary Material. We assessed the methodological quality of the studies and the strength of evidence for diverse outcomes.
Methods
We screened the electronic databases MEDLINE, SPORTDiscus, CINAHL, Embase, Cochrane and PEDro through September 2009 for intervention studies in adults and in children with any type of hematological cancer, and where they assessed physical activity. Additional studies were indentified from reference lists and the authors' knowledge of in press studies. The key words used (in various combinations) were exercise, physical activity, cardiorespiratory fitness, resistance training and hematological cancer, or leukemia, or lymphoma or myeloma. Inclusion criteria were the following: (1) studies limited to humans of any ethnic origin, (2) written in English, (3) full text (versus abstract only) available and (4) X50% of cancer patients/survivors used as study participants having hematological cancer diagnosis. One study 48 that stated participants were 'predominantly lymphoblastic leukemia' was assumed to imply at least half of survivors were hematological cancer and was included. Provided they met the criteria of 50% or more of the total survivor population having hematological cancer, we also included intervention exercise studies on HSCT patients regardless of their primary tumor site because many hematological cancer survivors undergo HSCT. For the purposes of this review, we used the North American definition of survivor, which includes individuals from the time of diagnosis onward.
Data extraction
We conducted a comprehensive qualitative review of the intervention studies. We extracted the information on the design of the study, demographics, type of cancer, intervention setting type of intervention (aerobic or resistance), degree of adherence, intervention length and main results. (For the observational studies included in Supplementary 
Quality assessment
Two independent reviewers (JRR, AL) scored the intervention studies, and a consensus meeting was arranged to sort out differences between both of them. The articles were not blinded for authors, institution and journal, because the reviewers who performed the quality assessment were familiar with the literature. The quality of the selected studies was scored using a quality assessment list (see Supplementary Table 2) . 49 The list included eight items on randomization, statistics, concurrent comparisons, adherence, participants lost to follow-up, reliability/validity of the exposure assessment, reliability/validity of the outcome and blinded measurement. The items on the list were rated as '1' (positive), '0' (negative) or '? ' (unclear) . For all studies, we calculated a total quality score by counting up the number of positive items (a total score between 0 and 8). Studies were rated as high quality if they met at least four of the following criteria: randomization, appropriate statistical testing (that is, intent-to-treat analysis, statistical significance reported), concurrent comparison group, at least 70% adherence to the intervention prescription, less than 20% of participants lost to follow-up, documented reliability/validity of the exposure assessment, documented reliability/validity of the outcome and blinded measurement. For studies that assessed multiple parameters in the same domain (for example, body weight, fat-free mass, fat mass, percent body fat), we considered the study to have a positive benefit if one of the outcomes showed significant improvement.
Levels of evidence
Three levels of evidence were constructed: (1) strong evidence: at least three high-quality intervention studies reported on the outcome and at least 75% reported a significant benefit (prepost intervention or between study arms); (2) weak evidence: at least three high-quality intervention studies evaluated the outcome, but fewer than 75% reported a significant effect; (3) insufficient evidence: if less than three high-quality intervention studies had evaluated the outcome (for efficiency purposes, we focused on outcomes examined by at least two studies).
Results
The information and quality assessment for each intervention study we revised is detailed in Supplementary Table 3 . The overall agreement between the two reviewers was 90% (k ¼ 0.813). Disagreement was solved in a consensus meeting. Detailed information on the intervention studies is provided in Supplementary Table 4 .
Adults
Adults not receiving HSCT. Seven publications from six studies [34] [35] [36] [37] [38] 50, 51 assessed the effects of exercise interventions on a range of outcomes. Three publications from two studies were randomized controlled trials (RCTs) studying a large (n ¼ 122) 37, 38 or small population sample (n ¼ 22), 36 and five publications were of high quality. [35] [36] [37] [38] 51 Chang et al. 36 reported that a brief 3-week walking intervention decreased fatigue intensity in adult acute myeloid leukemia survivors. Similarly, Blaauwbroek et al. 35 show that a minimal contact pedometer-based intervention could significantly increase physical activity and decrease fatigue in adult survivors of childhood cancer. In another low-intensity intervention, Cohen et al. 51 reported that once weekly yoga for 7 weeks had no effect on fatigue in lymphoma survivors. The highest quality evidence on the health benefits of exercise interventions in adults survivors of hematological cancer not receiving HCST arises from a large RCT by Courneya. 37 The authors reported that progressive aerobic activity three times a week for 12 weeks resulted in a significant improvement in fatigue in Hodgkin lymphoma/non-Hodgkin lymphoma survivors. 37 However, in follow-up 3 months after the intervention, the no-significant improvement remained.
There is mixed evidence of a benefit for aerobic activity on depression. Neither Chang et al. nor Cohen et al. reported an effect on depression. 36, 51 However, both interventions involved relatively low-intensity activity. In contrast, Courneya 37 reported that progressive aerobic activity resulted in a significant improvement in depression, which remained 3 months after the intervention ended. Neither of the two studies examining the effect of aerobic activity on anxiety found an effect. 37, 51 One study examined the effect on sleep and found a significant improvement in lymphoma survivors. 51 The study by Courneya 37 was the only study to examine global QOL and physical function. They found a significant improvement after the 12-week progressive aerobic activity intervention in Hodgkin lymphoma/non-Hodgkin lymphoma survivors. 37 In follow-up 3 months after the intervention, significant improvements remained. A subsequent analysis of the same study found that the intervention effect on QOL was modified by marital status such that unmarried survivors had better outcomes than married survivors. 38 Survivors in poor or fair health also had better QOL outcomes than those in good to excellent health.
Courneya 37 also found a significant improvement in body composition, but not body weight. The effect on body composition did not hold 3 months after the intervention ended. Finally, Courneya 37 reported a significant improvement in fitness. Two recent uncontrolled trials showed post-training improvements in the endurance capacity during cycle-ergometry exercise of adults with acute myeloid leukemia 34 or with various types of hematological cancer receiving aggressive chemotherapy. 50 A recent pilot trial did not show exercise caused problems in patients with median platelet count and hemoglobin levels of 27 000 per ml and 9.2 g/100 ml. 50 Platelet or blood transfusions were recommended before training when platelet count and hemoglobin levels were below 10 000 per ml and 8 g/100 ml, respectively.
Adults receiving HSCT. We located 17 publications from 13 studies, 39,40,52-66 8 of which 39, 40, 53, 54, 56, [63] [64] [65] were RCTs. Only two included a large population sample (nX100). 39, 40 Nine studies (comprising 13 publications) were of high quality. 39, 40, [52] [53] [54] [58] [59] [60] [61] [62] [63] [64] [65] Several exercise interventions for HSCT survivors took place during hospitalization 56, 58, 63 or started during hospitalization and continued after release, 40, 57, [59] [60] [61] [62] 64 whereas others were performed only in the outpatient or homebased setting. 39, [52] [53] [54] [55] 65, 66 Many interventions were aerobic and successfully increased functional capacity or at least offset the loss of functional capacity associated with HSCT. 40, 52, 55, 57, 61, 66 Not surprisingly, there is substantial interest in the ability of physical activity interventions to change blood markers in HSCT patients, with inconclusive results to date. An aerobic exercise intervention during the inpatient phase induced a significant pre-post change in hemoglobin concentration. 58 Kim and Kim 63 reported that 6 weeks of resistance training in the inpatient setting resulted in a significant improvement in lymphocyte count, yet, Hayes et al. 62 found that a 3-month combined aerobic and resistance training intervention (beginning inpatient and continuing after release) did not facilitate immune recovery.
No RCT has been published examining the effects of training interventions performed exclusively in the inpatient setting on fitness outcomes. The benefits of supervised interventions exclusively in the outpatient setting on fitness outcomes are not clearly established, with one uncontrolled trial showing improved endurance using a 30 min per day, 3 days per week for 12 weeks aerobic intervention. 52 Home-based interventions seem less successful at improving fitness as two studies found no increase in endurance. 53, 55 Shelton et al. 65 compared a supervised to a home-based intervention and found that both groups improved endurance with no change in physical function or fatigue. However, the exercise targets in the two intervention groups differed, challenging comparisons of the between-group differences.
Several studies assessed the effect of physical activity interventions on body composition in HSCT patients. In a home-based 6-month aerobic and resistance training intervention, Coleman et al. 53 found that controls lost weight whereas intervention participants increased weight. Hayes et al. 59 reported that the intervention group reduced percent body fat and increased fat-free mass versus pretreatment, but found no change in weight, body mass index or fat mass after a 3-month intervention of aerobic and resistance training. Cunningham et al. 56 found no significant change in body composition after a 6-week resistance training intervention. Wilson et al. 67 showed increased physical performance and some improvement in fatigue in survivors after HSCT, but no change in body mass index.
One of the areas that has seen consistent improvements in other cancer populations after physical activity is QOL. 49 The results for HSCT patients are less clear given the diversity of outcomes, but in general suggest a positive benefit. In an intervention setting after HSCT, Hayes et al. 60 found an increase in QOL in the intervention group, but not in the control group. However, the between-group difference was not significant. Wilson et al. 67 found significant improvements in QOL after a home-based intervention for some physical function-related QOL subscales and a reduction in fatigue severity. DeFor et al. 40 also reported that an aerobic intervention lasting for the first 100 days after transplant significantly improved physical and emotional well-being. Carlson et al. 52 found no significant change in anxiety and depression after outpatient intervention, but vigor increased and fatigue decreased. In contrast, Coleman and colleagues 53, 54 found no significant change in fatigue after a combined aerobic and resistance training intervention.
Evidence summary in adults (with or without HSCT). Of 24 separate publications in adults, 18 were rated as high quality. Strong evidence was found for a benefit of exercise on body composition in adult hematological cancer survivors (Table 1) . Weak, but promising, evidence exists for cardiorespiratory fitness, fatigue, muscle strength, physical functioning and QOL. Evidence was insufficient to draw a conclusion for the effects of exercise on sleep.
Children Pediatric survivors not receiving HSCT. Twelve studies, [42] [43] [44] [45] [46] [47] [48] [68] [69] [70] [71] [72] including two RCT 42, 44 and seven high-quality studies [42] [43] [44] [45] [46] 69, 71 evaluated the effects of physical activity interventions on outcomes in children with pediatric cancer who did not undergo HSCT. One study of high quality 68 evaluated the effects of a single (30 min) exercise bout. Evaluating the effects of exercise in this subpopulation poses numerous challenges. Pediatric tumors are relatively rare, but also involve debilitating treatment, resulting in recruitment challenges.
Several of the programs reported in the literature derive from physical therapy programs that are standard care in many non-US countries. These programs typically involve limited doses of supervised outpatient physical activity (generally very light resistance training) supplemented with home-based activities (usually aerobic activity). These interventions have typically not shown significant benefit in children surviving ALL, especially those that are home based.
In a 12-week intervention in the physical therapy setting after treatment, Marchese et al. 69 reported that supervised resistance training with home-based aerobic activity induced no change in ankle strength in ALL survivors (4-15 years). In a similar intervention lasting 12 weeks and involving 45 min of supervised resistance training twice a week followed by twice weekly home-based aerobic activity, Takken et al. 47 found no effect on strength in ALL survivors (6-14 years). A small intervention study that included supervised and home-based exercise did not increase strength or flexibility. In contrast, intrahospital, individually supervised training programs appear beneficial for young ALL survivors. San Juan et al. 71 reported that a 16-week combined aerobic and resistance training intervention of thrice weekly activity for 90-120 min significantly improved muscle strength in very young (4-7 years) pediatric ALL survivors in maintenance treatment phase. Improvements in muscle strength were evident after the first 8 weeks of training 46 and were maintained after a 20-week detraining period that followed the 16-week training program. 71 Similarly, these physical therapy programs showed no improvements in physical function 69 or functional mobility, 47 but the intrahospital program resulted in a significant improvement in functional mobility. 71 Marchese et al. 69 also reported that supervised resistance training with home-based aerobic activity resulted in improved ankle dorsiflexion range of motion, but San Juan et al. 71 found no improvement in a 16-week intrahospital combined aerobic and resistance intervention.
Exercise programs do improve fitness in pediatric patients. A 20-week aerobic intervention of thrice weekly activity for 30-40 min after treatment improved fitness in Hodgkin lymphoma survivors. 70 In a 12-month home-based aerobic and resistance training RCT, Moyer-Mileur et al. 44 found a significant increase in self-reported physical activity and fitness, but no increase in objectively measured physical activity (pedometer-measured steps). A small intervention study that included supervised and home-based exercise increased physical activity. 72 Shore and Shepard 48 reported that a 12-week aerobic intervention of 30 min of aerobic exercise that was partially supervised (that is, by a fitness professional once per week and by parents twice per week) significantly improved fitness in three pediatric ALL survivors (13-14 years) within 4 weeks of the conclusion of induction therapy. A recent community-based intervention showed improvements in physical activity levels and physical fitness in adolescents surviving cancer, though they returned to low physical activity levels shortly after they finished the program. 43 Intrahospital, individually supervised training programs also appear beneficial for young ALL survivors. San Juan et al. 71 reported that a 16-week combined aerobic and resistance training intervention of thrice weekly activity for 90-120 min significantly improved aerobic fitness in very young (4-7 years) pediatric ALL survivors in maintenance treatment phase. Despite improving fitness, interventions have not improved body composition. 42, 70, 72 As noted above, significant interest in the effects of exercise on blood markers exists for these patients. Marchese et al. 69 reported no change in hemoglobin in ALL survivors (4-15 years) participating in aerobic and resistance training. In contrast, Shore and Shepard 48 reported aerobic exercise tended to decrease CD3, CD4 and CD8 counts, though the change was not clinically significant, in three pediatric ALL survivors (13-14 years) within 4 weeks of the conclusion of induction therapy. Ruiz et al. 45 recently found no changes in growth hormone, insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding proteins in a combined (aerobic and resistance) training program in young (4-7 years) ALL survivors during maintenance treatment. Elevated levels of insulin-like growth factor-1 have been previously linked with increased cancer risk 73, 74 including leukemia. 75 In a sample of older (7-18 years) ALL survivors, Ladha et al.
68 reported no effect of a single acute exercise bout on white blood cells, monocytes or eosinophils, indicating no adverse immune response.
Physical therapy interventions have not shown to be effective in improving QOL. 69 However, a recent community-based intervention showed improvements in QOL in adolescents surviving cancer. 43 In contrast, the intrahospital intervention of San Juan et al. 71 showed no effect on QOL. As with other outcomes, limited supervision interventions, such as that of Takken et al. 47 , did not show any improvement in fatigue. However, a 20-week aerobic intervention of thrice weekly activity for 30-40 min after treatment reduced fatigue in Hodgkin lymphoma survivors. 70 Finally, Shore and Shepard 48 reported that a 12-week aerobic intervention of 30 min of Outcomes examined in at least two studies.
Exercise in hematological cancer survivors: a review KY Wolin et al aerobic exercise that was partially supervised (that is, by a fitness professional once per week and by parents twice per week) significantly improved anxiety (pre-post comparison) in three pediatric ALL survivors (13-14 years) within 4 weeks of the conclusion of induction therapy.
Pediatric survivors undergoing HSCT. Only two intervention studies (both of high quality, yet not RCT) are available in pediatric HSCT patients. 28, 41 Though more research is needed, the existing preliminary data are promising. In ALL and acute myeloid leukemia survivors in the outpatient setting (8-16 years) who received HSCT within the previous year, an 8-week intervention combining aerobic and resistance exercises resulted in a significant improvement in muscle strength, functional mobility, aerobic fitness and QOL. 28 A recent brief aerobic and resistance training intervention during inpatient hospitalization for HSCT resulted in significantly increased fitness and body mass with no deleterious effect on immune cell recovery. 41 Though preliminary, data suggest training during the neutropenic phase after HSCT (neutrophil count o0.5 Â 10 9 per l) did not increase risk of adverse events. 41 Side effects of exercise testing and training in hematological cancer survivors (adults and children, HSCT or not) undergoing treatment. As a function of the severely diminished capacity of hematological survivors during treatment, many individuals cannot complete exercise tolerance testing until treatment is over. 55 It has been noted that survivors may need to pause participation in the exercise intervention owing to treatment-related side effects. 40 As a result, achieving the study dose of physical activity proved to be a challenge. Participants may also drop out owing to medical complications. 56 Unfortunately, the effects of these interruptions on study outcomes are generally discussed in minimal detail and are not empirically evaluated. 58 Very little data are available on the ability of exercise training to affect treatment tolerance or efficacy. Courneya and colleagues 37 showed that aerobic training had no effect on treatment efficacy in a population of lymphoma survivors. They also reported the intervention had no effect on recurrence, but the study was also not powered to examine recurrence as an end point. DeFor et al. 40 also found no survival or length of stay effect of an intervention that began while survivors were admitted for allogeneic HSCT. Coleman et al. 39 found an exercise intervention decreased the number of transfusions needed in myeloma survivors.
Discussion
A growing body of literature has analyzed the effects of exercise interventions in adult and pediatric hematological cancer survivors. Though more RCT are needed, in adults we found strong evidence for a benefit of exercise training on body composition. In children, strong evidence exists for a benefit on muscle strength and cardiorespiratory fitness.
Exercise guidelines for the general population include detailed recommendations regarding aerobic, strength and flexibility, yet, at present this is not feasible for hematological cancer survivors undergoing any treatment regimen. First, an insufficient number of studies have evaluated the risks or benefits of flexibility interventions. This is clearly an area for future research. Also, research evaluating the effects of resistance training alone is clearly merited. Evidence suggests that resistance training is beneficial and safe, but as most interventions also include an aerobic component, it is difficult to parse out the effects of the training type. 28, 45, 60, 61 Nevertheless, it is noteworthy that no study has reported adverse outcomes associated with supervised progressive resistance training, including young survivors. Furthermore, exercise programs did have demonstrable benefits. In adults, programs that were at least 10 weeks in duration with a focus on structured or supervised aerobic activity reported benefits, though less evidence of a benefit was found if training started while survivors were in the inpatient setting.
Aerobic exercise interventions in hematological cancer survivors have been low to moderate intensity, using brief bouts at the start of the program and progressively increasing time and intensity. Despite indications that hematological cancer survivors may have diminished balance, research to date indicates walking and machine-based cycling are safe and may provide physiological and psychological benefits. Given the lack of research on extended bouts or activity of high intensity, it is recommended that survivors should be cautioned against this type of activity until its safety has been established.
In adults, research indicates benefits are more likely when activity occurs at least 3 days per week. Overall, a clear benefit for body composition is seen, but there is no demonstrated benefit for anxiety, fatigue, QOL or fitness. In general, it appears that, at least in adults, the benefit of physical activity interventions during treatment may be that of stabilization rather than performance/outcome improvement. Research in HSCT patients (with insufficient (o50% of total) hematological cancer survivors to be included in our review) has indicated exercise results in a significant change in hemoglobin, which may suggest a potential mechanism for some of the physical function and QOL benefits reported in the literature. 76 However, the generalizability of these findings to hematological cancer survivors is unclear and future research examining the mechanisms for the benefits of physical activity in this patient population is clearly warranted. Although one study 50 suggested a platelet and hemoglobin threshold for permitting patients to engage in exercise, the threshold has not been evaluated in trials. More research is thus needed to establish the minimum platelet count and hemoglobin levels required to ensure safety of training interventions. Future studies are also necessary with immunocompromised patients to establish the safety of exercise with regards to infection risk.
In pediatric survivors, supervised interventions have shown a greater benefit than home-based programs. On the basis of the limited available research, we conclude these interventions are most successful when performed inside the treating hospital, in part, to overcome the safety concerns expressed by some parents. Success is seen for programs occurring during active treatment, but also during the maintenance phase. Several interventions evaluated the effects of a physical therapy program bridging the inpatient and outpatient settings that is the standard of care in many settings, but these programs appear to have less benefit. Benefit was seen in studies with more intense contact, suggesting that this survivor population may require more supervised contact on a regular basis to achieve benefit.
Several specific limitations with the literature should be noted. Many of the studies lacked strong methods often due to a lack of control groups, incomplete randomization or failure to conduct intent-to-treat analyses after participant drop out. This may explain the lack of statistically significant findings for several of the studies, particularly in the pediatric population. Further limiting our ability to draw more firm conclusions, some studies recruited based on treatment modality (for example, HSCT or not) and others based on primary tumor site. The resulting challenge is that both treatment modality and diagnosis likely influence survivor's initial condition and may also modify intervention effectiveness, but no studies have been large enough to evaluate the interaction. Study populations are often small and mix populations both on diagnosis and treatment regimen. Only nine adult studies and two pediatric studies included randomized comparison group and studies often included survivors both on and off treatment. These limitations all likely to result from the relatively rare nature of these diagnoses, which makes recruiting challenges pervasive. 18 These recruiting challenges may also result in reduced generalizability of the study sample. Oldervall et al. 70 found that consenters had higher education, a concern as those of lower socioeconomic status tend to do worse on most health indicators. As noted above, several studies only analyzed those who remained in the study at follow-up or who adhered to the intervention. 51 Many studies did not report adherence rates 36 or reported rates that were rather low. 51 Finally, few studies assessed training effects on survivors' ability to cope with activities of daily living using appropriate, populationspecific tests.
Despite the noted limitations in the literature, a substantial and growing body of literature shows that physical activity appears safe and has numerous potential benefits for both adult and pediatric hematological cancer survivors.
